分子細胞遺伝学の世界市場分析:技術別(FISHおよびCGH)、用途別(遺伝的疾患、がん、オーダメイド医療)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Molecular Cytogenetics Market Analysis by Technology (FISH and CGH), by Application (Genetic Disorders, Cancer, Personalized Medicines) and Segment Forecasts To 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 – 2022
3.3 Molecular cytogenetics market dynamics
3.3.1 Market driver analysis
3.3.2 Introduction of advanced technologies
3.3.3 Rising incidence of cancer
3.3.4 Advent of Next Generation Sequencing
3.3.5 Market restraint analysis
3.3.6 Issues with medical reimbursement
3.4 Key Opportunities Prioritized: Technology
3.5 Industry analysis Porter’s
3.6 Molecular cytogenetics PESTEL Analysis
Chapter 4 Molecular Cytogenetics Technology Outlook
4.1 Molecular cytogenetics revenue share by technology, 2014 & 2022
4.2 FISH
4.2.1 FISH market, 2012 – 2022 (USD Million)
4.3 CGH
4.3.1 CGH market, 2012 – 2022 (USD Million)
Chapter 5 Molecular Cytogenetics Application Outlook
5.1 Molecular cytogenetics revenue share by application, 2014 & 2022
5.2 Genetic disorders
5.2.1 Genetic disorders market, 2012 – 2022 (USD Million)
5.3 Cancer
5.3.1 Cancer market, 2012 – 2022 (USD Million)
5.4 Personalized medicine
5.4.1 Personalized medicine market, 2012 – 2022 (USD Million)
5.5 Others (Neurological, Cardiovascular, and Infectious Diseases)
5.5.1 Others market, 2012 – 2022 (USD Million)
Chapter 6 Molecular Cytogenetics Regional Outlook
6.1 Molecular cytogenetics market share, by region, 2014 & 2022
6.2 North America
6.2.1 North America molecular cytogenetics market 2012 – 2022 (USD Million)
6.3 Europe
6.3.1 Europe molecular cytogenetics market, 2012 – 2022 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific molecular cytogenetics market, 2012 – 2022 (USD Million)
6.5 RoW
6.5.1 RoW molecular diagnostics market, 2012 – 2022 (USD Million)
Chapter 7 Competitive Landscape
7.1 Affymetrix, Inc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Agilent Technologies, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Applied Spectral Imaging, Inc.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 BI Biological Industries, Inc.
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Thermo Fisher Scientific, Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Oxford Gene Technologies, Inc.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 CytoTest, Inc.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Cytognomix, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:分子細胞遺伝学の世界市場分析:技術別(FISHおよびCGH)、用途別(遺伝的疾患、がん、オーダメイド医療)、セグメント予測
■ 英文:Molecular Cytogenetics Market Analysis by Technology (FISH and CGH), by Application (Genetic Disorders, Cancer, Personalized Medicines) and Segment Forecasts To 2022
■ 発行日:2016年8月14日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707557
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。